Insider · CIK 0001378796

Lindblom Christopher M

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001378796

Forms 4 and 5

Insider transactions

14 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-05-02	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+40K sh	—	—	40,000
2015-03-07	DNIB UNWIND, INC.Employee Stock Option (Right to Buy)A Award	SVP, FINANCE & ADMINISTRATION	AAward	+45K sh	—	—	45,000
2013-06-07	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	Vice President of Finance	AAward	+93.8K sh	—	—	93,846
2013-01-04	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+14.9K sh	—	—	14,941
2012-11-26	INFINITY PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+3,885 sh	$9.80	+$38.1K	13,885
2012-11-26	INFINITY PHARMACEUTICALS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+10K sh	$14.33	+$143K	10,000
2012-11-26	INFINITY PHARMACEUTICALS, INC.S Sale	Principal Accounting Officer	SSale	−13.9K sh	$25.73	−$357K	0
2012-11-26	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−10K sh	—	—	10,000
2012-11-26	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−3,885 sh	—	—	0
2012-01-06	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+30.1K sh	—	—	30,104
2011-01-06	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+9,828 sh	—	—	9,828
2010-07-29	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+27K sh	—	—	27,000
2010-01-05	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+9,238 sh	—	—	9,238
2008-12-04	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+7,555 sh	—	—	7,555

Recent filings

Accepted (ET)
May 44
INFINITY PHARMACEUTICALS, INC.0000899243-16-019200
SEC(opens sec.gov)
Mar 104
BIND Therapeutics, Inc0001181431-15-004448
SEC(opens sec.gov)
Jun 114
OvaScience, Inc.0001104659-13-048348
SEC(opens sec.gov)
Jan 84
Lindblom Christopher M0001181431-13-002242
SEC(opens sec.gov)
Nov 274
Lindblom Christopher M0001181431-12-060719
SEC(opens sec.gov)
Jan 94
Lindblom Christopher M0001209191-12-002719
SEC(opens sec.gov)
Jan 74
Lindblom Christopher M0001181431-11-002568
SEC(opens sec.gov)
Aug 24
Lindblom Christopher M0001181431-10-039508
SEC(opens sec.gov)
Jan 74
Lindblom Christopher M0001181431-10-002140
SEC(opens sec.gov)
Dec 84
INFINITY PHARMACEUTICALS, INC.0001181431-08-066048
SEC(opens sec.gov)

Companies

Address

C/O INFINITY PHARMACEUTICALS, INC. 780 MEMORIAL DRIVE

CAMBRIDGE, MA, 02139